NCT03586219

Postoperative Opioid Consumption After Urogyneocologic Surgery

Completed NA Last updated 15 April 2021

What this trial tests

NA trial testing Opioid-specific educational patient pamphlets in Pelvic Organ Prolapse in 146 participants. Completed in 28 November 2020.

Timeline

29 December 2017

Primary endpoint
28 November 2020

28 November 2020

Quick facts

Lead sponsor	University of California, Irvine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	146
Start date	29 December 2017
Primary completion	28 November 2020
Estimated completion	28 November 2020
Sites	3 locations across United States

Drugs / interventions tested

• Opioid-specific educational patient pamphlets

Conditions studied

• Pelvic Organ Prolapse — all drugs for Pelvic Organ Prolapse →

Sponsor

University of California, Irvine

Who can join

Adults 18 to 99, female only, with Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this randomized controlled trial is to evaluate whether preoperative opioid education will reduce postoperative opioid consumption after urogynecologic surgeries. Additionally, the effect of the opioid education on opioid storage and disposal patterns will be evaluated. The pattern of opioid consumption 2 and 6 weeks after surgery will be compared between patients in the study arms. The rates of prescription refills 12 weeks and 12 months after the surgery will be compared between patients in the study arms.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Reducing opioid consumption levels post-operatively following gastrointestinal surgery - A systematic review of randomized trials.
   Davey MG, Joyce WP. · · 2022 · cited 1× · PMID 39845591 · DOI 10.1016/j.sipas.2022.100093